Companies’ overall clinical trial transparency rankings for drugs approved in 2014*
| Rank | Company | Transparency score (%) |
| #1 | Johnson & Johnson/Janssen | 100 |
| #1 | Sanofi/Genzyme | 100 |
| #3 | Abbvie | 96 |
| #4 | Celgene | 95 |
| #5 | Merck | 93 |
| #6 | AstraZeneca | 91 |
| #7 | Roche | 90 |
| #8 | Novartis | 88 |
| #9 | Gilead | 73 |
| #10 | Allergan | 63 |
| #11 | Valeant | 50 |
| Median | 91 |
*Based on the average of companies’ scores for (1) the trials-in-patients analysis and (2) FDAAA compliance measure that counted a trial as compliant if it satisfied either interpretation of the reporting requirements.
FDAAA, Food and Drug Administration Amendments Act.